A controlled study of intravenous doxorubicin versus oral tegafur in patients with hepatocellular carcinoma.
D000284:Administration, Oral; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D005641:Tegafur / Q000008:administration & dosage / Q000627:therapeutic use*
D005641:Tegafur; D004317:Doxorubicin